Back
Thursday, 19 Nov, 2020
Coronavirus: hope builds after Pfizer-BioNTech says final analysis shows vaccine 95 per cent effective (South China Morning Post)
A major milestone in the race for a vaccine to counter COVID-19 was reached on Wednesday, when the first vaccine developers to complete phase 3 trials announced results in what has been the fastest vaccine development in history. The vaccine, developed by German firm BioNTech SE and American company Pfizer Inc, far exceeded a regulatory bar, showing 95 per cent efficacy in the final analysis of their global clinical trial, according to a company statement.
Original article: Coronavirus: hope builds after Pfizer-BioNTech says final analysis shows vaccine 95 per cent effective (South China Morning Post)